Yi, Z. et al. Strand-selective base editing of human mitochondrial DNA using mitoBEs. Nat. Biotechnol. 42, 498–509 (2024).
Brandon, M. C. et al. MITOMAP: a human mitochondrial genome database–2004 update. Nucleic Acids Res. 33, D611–D613 (2005).
Greaves, L. C., Reeve, A. K., Taylor, R. W. & Turnbull, D. M. Mitochondrial DNA and disease. J. Pathol. 226, 274–286 (2012).
Ng, Y. S. & Turnbull, D. M. Mitochondrial disease: genetics and management. J. Neurol. 263, 179–191 (2016).
Lightowlers, R. N., Chinnery, P. F., Turnbull, D. M. & Howell, N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet. 13, 450–455 (1997).
Finsterer, J. Leigh and Leigh-like syndrome in children and adults. Pediatr. Neurol. 39, 223–235 (2008).
Wallace, D. C. et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 242, 1427–1430 (1988).
Baertling, F. et al. A guide to diagnosis and treatment of Leigh syndrome. J. Neurol. Neurosurg. Psychiatry 85, 257–265 (2014).
Meyerson, C., Van Stavern, G. & McClelland, C. Leber hereditary optic neuropathy: current perspectives. Clin. Ophthalmol. 9, 1165–1176 (2015).
Rahman, S. Mitochondrial disease in children. J. Intern. Med. 287, 609–633 (2020).
La Morgia, C., Maresca, A., Caporali, L., Valentino, M. L. & Carelli, V. Mitochondrial diseases in adults. J. Intern. Med. 287, 592–608 (2020).
Magner, M., Kolarova, H., Honzik, T., Svandova, I. & Zeman, J. Clinical manifestation of mitochondrial diseases. Dev. Period Med. 19, 441–449 (2015).
Wallace, D. C. Mouse models for mitochondrial disease. Am. J. Med. Genet. 106, 71–93 (2001).
Stewart, J. B. Current progress with mammalian models of mitochondrial DNA disease. J. Inherit. Metab. Dis. 44, 325–342 (2021).
Zhang, D. et al. Construction of transgenic mice with tissue-specific acceleration of mitochondrial DNA mutagenesis. Genomics 69, 151–161 (2000).
Bacman, S. R., Williams, S. L., Pinto, M., Peralta, S. & Moraes, C. T. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat. Med. 19, 1111–1113 (2013).
Gammage, P. A., Rorbach, J., Vincent, A. I., Rebar, E. J. & Minczuk, M. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. EMBO Mol. Med. 6, 458–466 (2014).
Mok, B. Y. et al. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature 583, 631–637 (2020).
Cho, S. I. et al. Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases. Cell 185, 1764–1776 (2022).
Zhang, X. & Wei, W. CRISPR-free, strand-selective mitochondrial DNA base editing using a nickase. Nat. Biotechnol. 42, 392–393 (2024).
Harris, R. S., Petersen-Mahrt, S. K. & Neuberger, M. S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10, 1247–1253 (2002).
Saraconi, G., Severi, F., Sala, C., Mattiuz, G. & Conticello, S. G. The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas. Genome Biol. 15, 417 (2014).
Tunyasuvunakool, K. et al. Highly accurate protein structure prediction for the human proteome. Nature 596, 590–596 (2021).
Losey, H. C., Ruthenburg, A. J. & Verdine, G. L. Crystal structure of Staphylococcus aureus tRNA adenosine deaminase TadA in complex with RNA. Nat. Struct. Mol. Biol. 13, 153–159 (2006).
Grunewald, J. et al. CRISPR DNA base editors with reduced RNA off-target and self-editing activities. Nat. Biotechnol. 37, 1041–1048 (2019).
Ma, Y. et al. Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells. Nat. Methods 13, 1029–1035 (2016).
Thuronyi, B. W. et al. Continuous evolution of base editors with expanded target compatibility and improved activity. Nat. Biotechnol. 37, 1070–1079 (2019).
Gehrke, J. M. et al. An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities. Nat. Biotechnol. 36, 977–982 (2018).
Wang, X. et al. Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion. Nat. Biotechnol. 36, 946–949 (2018).
Neugebauer, M. E. et al. Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity. Nat. Biotechnol. 41, 673–685 (2023).
Chen, L. et al. Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing. Nat. Biotechnol. 41, 663–672 (2023).
Zhang, E., Neugebauer, M. E., Krasnow, N. A. & Liu, D. R. Phage-assisted evolution of highly active cytosine base editors with enhanced selectivity and minimal sequence context preference. Nat. Commun. 15, 1697 (2024).
Grau, J., Boch, J. & Posch, S. TALENoffer: genome-wide TALEN off-target prediction. Bioinformatics 29, 2931–2932 (2013).
Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).
Qu, L. et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell 185, 1728–1744 (2022).
Su, X. et al. Molecular basis of the pathogenic mechanism induced by the m.9191T>C mutation in mitochondrial ATP6 gene. Int. J. Mol. Sci. https://doi.org/10.3390/ijms21145083 (2020).
Peverelli, L. et al. Leber’s hereditary optic neuropathy: a report on novel mtDNA pathogenic variants. Front. Neurol. 12, 657317 (2021).
Zhang, H., Burr, S. P. & Chinnery, P. F. The mitochondrial DNA genetic bottleneck: inheritance and beyond. Essays Biochem. 62, 225–234 (2018).
Fan, W. et al. A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science 319, 958–962 (2008).
Silva-Pinheiro, P. et al. A library of base editors for the precise ablation of all protein-coding genes in the mouse mitochondrial genome. Nat. Biomed. Eng. 7, 692–703 (2023).
Cho, S. I. et al. Engineering TALE-linked deaminases to facilitate precision adenine base editing in mitochondrial DNA. Cell 187, 95–109 (2024).
Yu-Wai-Man, P., Turnbull, D. M. & Chinnery, P. F. Leber hereditary optic neuropathy. J. Med. Genet. 39, 162–169 (2002).
Krylova, T. D. et al. Three rare pathogenic mtDNA substitutions in LHON patients with low heteroplasmy. Mitochondrion 50, 139–144 (2020).
Zhang, Y. et al. Deciphering TAL effectors for 5-methylcytosine and 5-hydroxymethylcytosine recognition. Nat. Commun. 8, 901 (2017).
Yang, J. et al. Complete decoding of TAL effectors for DNA recognition. Cell Res. 24, 628–631 (2014).
Yang, J. et al. ULtiMATE system for rapid assembly of customized TAL effectors. PLoS ONE 8, e75649 (2013).
Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224–226 (2019).
Picardi, E. & Pesole, G. REDItools: high-throughput RNA editing detection made easy. Bioinformatics 29, 1813–1814 (2013).
Van der Auwera, G. A. et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr. Protoc. Bioinformatics 43, 11.10.11–11.10.33 (2013).
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
